Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Gaush Meditech Ltd. ( (HK:2407) ) has shared an update.
Gaush Meditech Ltd has updated its shareholder communication practices to comply with new Hong Kong listing rules, shifting primarily to electronic dissemination of corporate documents. Future actionable corporate communications will be sent to shareholders by email where addresses are available, while broader corporate communications will be posted on the company’s and the stock exchange’s websites without separate publication notices.
Shareholders who do not provide a functional email address will continue to receive actionable materials in print, along with a request to submit an email address for future use. Investors who prefer printed copies of all corporate and actionable communications may opt in free of charge by written request, though such preferences must be renewed periodically, reflecting a broader market move toward digital-first, cost-efficient and environmentally friendly disclosure practices.
The most recent analyst rating on (HK:2407) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on Gaush Meditech Ltd. stock, see the HK:2407 Stock Forecast page.
More about Gaush Meditech Ltd.
Gaush Meditech Ltd is a Cayman Islands–incorporated company listed on the Hong Kong Stock Exchange under stock code 2407. The company communicates regularly with its shareholders and the investing public through corporate documents such as financial reports, circulars, meeting notices, and other investor relations materials.
Average Trading Volume: 41,901
Technical Sentiment Signal: Sell
Current Market Cap: HK$945M
See more insights into 2407 stock on TipRanks’ Stock Analysis page.